Statins and dilated cardiomyopathy: do we have enough data?
about
Lipid-lowering therapy in older personsLipids, blood pressure, kidney - what was new in 2011?Differences in Clinical Presentation and Findings between Idiopathic Dilated and Ischaemic Cardiomyopathy in an Unselected Population of Heart Failure Patients.The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up.Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy: editorial to "Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice" by K. Tajiri et al.
P2860
Statins and dilated cardiomyopathy: do we have enough data?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Statins and dilated cardiomyopathy: do we have enough data?
@ast
Statins and dilated cardiomyopathy: do we have enough data?
@en
type
label
Statins and dilated cardiomyopathy: do we have enough data?
@ast
Statins and dilated cardiomyopathy: do we have enough data?
@en
prefLabel
Statins and dilated cardiomyopathy: do we have enough data?
@ast
Statins and dilated cardiomyopathy: do we have enough data?
@en
P2093
P2860
P50
P1476
Statins and dilated cardiomyopathy: do we have enough data?
@en
P2093
Jacek Rysz
Simon Hannam
Wilbert S Aronow
P2860
P304
P356
10.1517/13543784.2011.550570
P407
P577
2011-01-06T00:00:00Z